PD-1/PD-L1 and DNA Damage Response in Cancer

The application of immunotherapy for cancer treatment is rapidly becoming more widespread. Immunotherapeutic agents are frequently combined with various types of treatments to obtain a more durable antitumor clinical response in patients who have developed resistance to monotherapy. Chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kciuk, Mateusz, Kołat, Damian, Kałuzińska-Kołat, Żaneta, Gawrysiak, Mateusz, Drozda, Rafał, Celik, Ismail, Kontek, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954559/
https://www.ncbi.nlm.nih.gov/pubmed/36831197
http://dx.doi.org/10.3390/cells12040530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954559/
https://www.ncbi.nlm.nih.gov/pubmed/36831197
http://dx.doi.org/10.3390/cells12040530

Ejemplares similares